PRC
IART icon

Pearl River Capital’s Integra LifeSciences IART Stock Holding History

Pearl River Capital’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,506
Closed -$201K – 543
2023
Q1 		$201K Buy
+3,506
New +$198K 0.03% 459
2020
Q2 		– Sell
-2,237
Closed -$100K – 430
2020
Q1 		$100K Buy
+2,237
New +$117K 0.19% 169
2019
Q1 		– Sell
-100
Closed -$5K – 541
2018
Q4 		$5K Buy
+100
New +$5.49K 0.02% 713

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pearl River Capital's IART Position: Q2 2023 in Review

Pearl River Capital sold out of Integra LifeSciences (IART) in Q2 2023, closing a stake of 3,506 shares — an estimated $201K sold.

Pearl River Capital first reported a position in IART in Q4 2018 and held it in 3 quarters. The position peaked at $201K in Q1 2023. 283 funds tracked by Wall St. Rank hold IART as of Q2 2023.

  • Pearl River Capital reported no remaining Integra LifeSciences position as of Q2 2023 after selling out during the quarter.
  • Pearl River Capital sold 3,506 Integra LifeSciences shares in Q2 2023, an estimated $201K.
  • Pearl River Capital first reported a position in Integra LifeSciences in Q4 2018 and held it in 3 quarters.
  • Pearl River Capital's Integra LifeSciences position peaked at $201K in Q1 2023.
  • 283 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2023.

Based on Pearl River Capital's 13F filing for Q2 2023, filed 11 Aug 2023.